Overview

Endogenous Opioid Response to Injections

Status:
RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This study will study pain relief after spine injections that are used to guide care. Some improvements in pain from a procedure might be from placebo effect rather than the physiological effect of the procedure. The study will use naloxone to reverse the effect of the body's internal placebo system after a spine injection, so the placebo effect and the injection effect can be measured separately. This process may improve the understanding of spine injections and their ability to guide pain care.
Phase:
PHASE4
Details
Lead Sponsor:
Middle Tennessee Research Institute
Collaborator:
International Pain and Spine Intervention Society